Free Trial

ZIVO Bioscience (NASDAQ:ZIVO) Stock Passes Above 50 Day Moving Average - Here's Why

ZIVO Bioscience logo with Medical background

Key Points

  • ZIVO Bioscience's stock price has crossed above its fifty day moving average of $14.36, reaching a high of $18.99 during trading.
  • The company has a market cap of $72.48 million and operates in the biotech and agtech sectors, focusing on natural bioactive ingredients derived from proprietary algae cultures.
  • ZIVO Bioscience's P/E ratio stands at -3.89, indicating negative earnings, which is reflected in its beta of -0.06.
  • Need better tools to track ZIVO Bioscience? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

ZIVO Bioscience, Inc. (NASDAQ:ZIVO - Get Free Report)'s stock price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $14.36 and traded as high as $18.99. ZIVO Bioscience shares last traded at $18.99, with a volume of 290 shares traded.

ZIVO Bioscience Stock Performance

The firm has a market cap of $72.48 million, a P/E ratio of -3.89 and a beta of -0.06. The company has a 50-day moving average of $14.36 and a 200 day moving average of $16.29.

ZIVO Bioscience Company Profile

(Get Free Report)

ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in ZIVO Bioscience Right Now?

Before you consider ZIVO Bioscience, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZIVO Bioscience wasn't on the list.

While ZIVO Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines